[Beta-blockers in patients undergoing noncardiac surgery: implications of the POISE study]

Rev Esp Anestesiol Reanim. 2009 Apr;56(4):232-8. doi: 10.1016/s0034-9356(09)70377-9.
[Article in Spanish]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / adverse effects
  • Adrenergic beta-Antagonists / pharmacology*
  • Adrenergic beta-Antagonists / therapeutic use
  • Bradycardia / chemically induced
  • Bradycardia / epidemiology
  • Contraindications
  • Female
  • Forecasting
  • Heart / drug effects
  • Heart Arrest / epidemiology
  • Hemodynamics / drug effects
  • Humans
  • Intraoperative Complications / chemically induced
  • Intraoperative Complications / epidemiology
  • Intraoperative Complications / prevention & control
  • Male
  • Meta-Analysis as Topic
  • Metoprolol / administration & dosage
  • Metoprolol / adverse effects
  • Metoprolol / pharmacology
  • Monitoring, Intraoperative
  • Multicenter Studies as Topic / statistics & numerical data
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / etiology
  • Postoperative Complications / chemically induced
  • Postoperative Complications / epidemiology
  • Postoperative Complications / prevention & control
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Risk
  • Stroke / epidemiology
  • Stroke / etiology
  • Surgical Procedures, Operative*

Substances

  • Adrenergic beta-Antagonists
  • Metoprolol